News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Consumer Group to FDA: Pull Novo Nordisk A/S (NVO)'s Victoza Off the Market


4/20/2012 7:04:44 AM

Novo Nordisk A/S (NOVOB) said it rejects assertions by the U.S. group Public Citizen that the diabetes drug Victoza should be pulled from the market.

“Novo Nordisk is committed to patient safety and rejects Public Citizen’s assertion that the benefits of Victoza are outweighed by its risks,” the Bagsvaerd, Denmark-based company said in an e-mailed statement late yesterday.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES